ArticleTranslational pediatrics2026

Precision myeloablation with TDM-guided busulfan in pediatric primary immunodeficiencies: a real-world study of 28 patients.

Kaige Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.